在高风险的骨髓质疏松症候群中,没有新疗法
Athanasios G Galanopoulos1, Christina Papi1
1Euroclinic Athens, Hematology Clinic, Athens, Greece.
European journal of haematology
|February 24, 2026
概括
风险较高的骨髓质疏松症候群 (MDS) 尽管有目前的治疗方法,但结果不佳. 新型疗法显示出希望,但与低甲基化剂的联合治疗尚未比单一疗法提高疗效.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 骨髓质综合征 (MDS) 是一种异质的克隆性骨髓瘤.
- 高风险的MDS (HR-MDS) 容易发生急性髓性白血病 (AML) 的进展.
- 目前的治疗方法,如全源干细胞移植 (HSCT) 和低甲基化剂 (HMA) 提供了低于最佳的结果.
研究的目的:
- 审查HR-MDS的新型治疗策略.
- 总结新兴治疗方法的作用机制和疗效.
- 突出对更有效的HR-MDS疗法的未满足需求.
主要方法:
- 关于HR-MDS疗法的最新进展的文献综述.
- 对包括BCL-2,IDH1/2,CD47,TIM-3,XPO1,NEDD8激活酶,TP53抑制剂和脂质体化疗等新药的分析.
- 评估与HMAs的组合疗法.
主要成果:
- 许多新的向疗法正在为HR-MDS进行研究.
- 在初步研究中,HMA与新药的组合并没有显示出优于HMA单一疗法的疗效.
- 在理解HR-MDS生物学和开发向治疗方面取得了重大进展.
结论:
- 尽管取得了进展,但HR-MDS的有效疗法仍然是一个未满足的需求.
- 新药提供了新的途径,但最佳治疗策略仍在发展.
- 进一步的研究对于改善HR-MDS患者的治疗结果至关重要.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Bone Marrow Sampling and Transplants
1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K


